Back to mobile site

"Presentations Will Further Support ibrexafungerp" - Cantor Fitzgerald SCYNEXIS (SCYX) at Overweight

October 11, 2022 9:24 AM EDT Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $30.00 price target on SCYNEXIS (NASDAQ: SCYX), following the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login